HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

VEGF expression correlates with microvessel density in Philadelphia chromosome-negative chronic myeloproliferative disorders.

Abstract
We examined microvessel density (MVD) and immunohistochemical expression of vascular endothelial growth factor (VEGF) in the bone marrow biopsy specimens of 98 patients with Philadelphia chromosome-negative (Ph-) chronic myeloproliferative disorders (CMPDs). There were significantly more MVD "hot spots" in chronic idiopathic myelofibrosis (CIMF; mean +/- SD, 25.6 +/- 6.3) and polycythemia vera (PV; 20.7 +/- 10.2) cases than in essential thrombocythemia (ET) cases (10.1 +/- 4.5) and normal control (NC) samples (7.5 +/- 3.6) (P < .05). Similar results were found using a semiquantitative method (P < .0001). A calculated VEGF index (VEGF(i)) was higher in CIMF (0.29 +/- 0.15) and PV (0.28 +/- 0.20) cases than in ET (0.12 +/- 0.05) and NC (0.08 +/- 0.04) cases (P < .0001). MVD and VEGF(i) were higher in the myelofibrotic phases of CIMF and PV. There was a direct correlation between VEGF(i) and MVD when considering the Ph- CMPDs together (r = 0.67; P < .001) and when considering PV (r = 0.79; P < .001) and CIMF (r = 0.40; P = .013) as individual entities. Our data could provide a rationale for directly targeting VEGF or endothelial cells in CIMF and PV.
AuthorsUmberto Gianelli, Claudia Vener, Paola Rafaniello Raviele, Federica Savi, Francesco Somalvico, Rossella Calori, Alesndra Iurlo, Franca Radaelli, Elisa Fermo, Paolo Bucciarelli, Silvano Bori, Guido Coggi, Giorgio Lambertenghi Deliliers
JournalAmerican journal of clinical pathology (Am J Clin Pathol) Vol. 128 Issue 6 Pg. 966-73 (Dec 2007) ISSN: 0002-9173 [Print] England
PMID18024322 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers (metabolism)
  • Bone Marrow (blood supply, pathology)
  • Chronic Disease
  • DNA Mutational Analysis
  • Female
  • Humans
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (metabolism, pathology)
  • Male
  • Microcirculation (metabolism, pathology)
  • Middle Aged
  • Neovascularization, Pathologic (metabolism, pathology)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: